文献速递炎症性肠病

克罗恩病肛周瘘的现代管理:未来方向

Modern management of perianal fistulas in Crohn's disease: future directions.
PubMed 文献 · Gut · 2018-01-13

本文综述克罗恩病肛周瘘的现代管理及最新进展,指出尽管引入抗肿瘤坏死因子等新药,联合内外科治疗的最佳瘘愈合率仍约50%。文章探讨新旧生物制剂、细胞治疗及内镜和手术新技术的优化应用,展望改善预后的方向。

要点

  • 克罗恩病肛周瘘显著影响生活质量,需消化科、结直肠外科、内镜和放射科多学科协作管理。
  • 尽管使用抗肿瘤坏死因子等新药,联合内外科治疗的最佳瘘愈合率仍约为50%。
  • 新型生物制剂、细胞治疗及内镜和手术新技术有望改善预后,本综述探讨其优化应用。

核心结论

  • 现代管理采用多学科模式,但联合治疗最佳瘘愈合率仍约50%,新型生物制剂、细胞治疗及内镜和手术新技术有望改善结局。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 过去二十年克罗恩病肛周瘘管理取得显著进展,发展为包括消化科、结直肠外科、内镜和放射科的多学科模式。
  • 尽管引入抗肿瘤坏死因子等新药和新型照护模式,联合内外科治疗的最佳瘘愈合率仍约为50%。
  • 近期引入的新型生物制剂、细胞治疗及新型内镜和手术技术带来改善结局的新希望。

临床怎么用

  • 本综述描述复杂肛周瘘性克罗恩病的现代管理和最新进展,探讨新旧生物制剂及细胞治疗的优化使用,并讨论内镜和手术新技术的应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Perianal fistulae in patients with Crohn's disease (CD) can be associated with significant morbidity resulting in negative impact on quality of life. The last two decades have seen significant advancements in the management of perianal fistulas in CD, which has evolved into a multidisciplinary approach that includes gastroenterologists, colorectal surgeons, endoscopists and radiologists. Despite the introduction of new medical therapies such as antitumour necrosis factor and novel models of care delivery, the best fistula healing rates reported with combined medical and surgical approaches are approximately 50%. More recently, newer biologics, cell-based therapies as well as novel endoscopic and surgical techniques have been introduced raising new hopes that outcomes can be improved upon. In this review, we describe the modern management and the most recent advances in the management of complex perianal fistulising CD, which will likely impact clinical practice. We will explore optimal use of both older and newer biological agents, as well as new data on cell-based therapies. In addition, new techniques in endoscopic and surgical approaches will be discussed.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Kotze PG, Shen B, Lightner A, et al. Modern management of perianal fistulas in Crohn's disease: future directions. Gut. 2018. PMID: 29331943. doi:10.1136/gutjnl-2017-314918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。